Effect of Hemostatic Device With Quantitative Pressure on Radial Artery Hemostasis After PCI

Sponsor
Peking University First Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05790603
Collaborator
(none)
220
1
4
17.1
12.9

Study Details

Study Description

Brief Summary

The objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after percutaneous coronary intervention. The main questions aims to answer:

  • What is the hemostatic effect of the quantitative pressure hemostatic device after percutaneous coronary intervention?

  • What are the precise hemostasis pressure and hemostasis time of the radial artery after percutaneous coronary intervention? Participants will be randomly assigned to the intervention group (IG) and control group (CG). The IG will use quantitative pressure patent hemostasis, which will be subdivided into three groups: low pressure group, medium pressure group and high pressure group. The CG will use the conventional radial artery hemostatic device without pressure monitoring.

The primary outcomes are hemostasis success and incidence of radial artery occlusion. Secondary outcomes include time to hemostasis, rate of bleeding, hematoma, pain, hand swelling, pseudoaneurysm, antebrachial osteofascial compartment syndrome and oxygen saturation of the compressed side thumb.

Condition or Disease Intervention/Treatment Phase
  • Device: Experimental: Low pressure group of quantitative pressure patent hemostasis
  • Device: Experimental: Medium pressure group of quantitative pressure patent hemostasis
  • Device: Experimental: High pressure group of quantitative pressure patent hemostasis
  • Device: Active Comparator: Conventional radial artery hemostat device
N/A

Detailed Description

The objective of this clinical trial is to compare the hemostatic effect of 2 hemostatic devices with or without quantitative pressure on radial arteries after percutaneous coronary intervention. The main questions aims to answer:

  • What is the hemostatic effect of the quantitative pressure hemostatic device after percutaneous coronary intervention?

  • What are the precise hemostasis pressure and hemostasis time of the radial artery after percutaneous coronary intervention? Participants will be randomly assigned to the intervention group (IG) and control group (CG).

The IG will use quantitative pressure patent hemostasis, which will be subdivided into three groups: low pressure group, medium pressure group and high pressure group. The IG will use a compression pressure of 120% ,125% or 130% of preoperative upper limb systolic blood pressure after PCI for low, medium, or high pressure group . For the participants assigned to the IG, we will use the quantitative pressure patent hemostasis after the percutaneous coronary intervention. After that, the hemostasis pressure is reduced in a certain gradient every hour until the hemostasis is successful.

For the participants assigned to the CG, we will use the hemostatic device (traditionally used in Peking University First Hospital) after percutaneous coronary intervention, and then release the tourniquet hourly based on traditional experience to reduce the hemostatic pressure until the hemostasis is successful.

For all enrolled participants, we should record the complications such as bleeding, hematoma, pain, oxygen saturation of compressed thumb and hand swelling in the patient immediately and hourly after the operation. Radial artery occlusion and radial artery thrombosis were confirmed by arterial ultrasound at 24 hours (ward) and postoperative day 30 (follow-up clinic).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
220 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
One of the primary outcome of radial artery occlusion will be assessed by masking the assessor. The data analyzers will also be blinded.
Primary Purpose:
Prevention
Official Title:
Effect of Hemostatic Device With Quantitative Pressure on Radial Artery Hemostasis After Percutaneous Coronary Intervention:a Randomized Controlled Trial
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Low pressure group

This group will use the radial artery hemostatic device with quantitative pressure which will be the new patent product made by Shandong Weigao Group Medical Polymer Products Co. LTD,China. The compression pressure on radial artery after PCI was 120% of upper arm systolic BP measured preoperatively. Pressure will be released by 4% hourly until the bleeding is stopped.

Device: Experimental: Low pressure group of quantitative pressure patent hemostasis
The compression pressure was 120% of upper SBP. Pressure will be released by 4% hourly until the bleeding is stopped.

Experimental: Medium pressure group

This group will use the radial artery hemostatic device with quantitative pressure which will be the new patent product made by Shandong Weigao Group Medical Polymer Products Co. LTD,China. The compression pressure on radial artery after PCI was 125% of upper arm systolic BP measured preoperatively. Pressure will be released by 5% hourly until the bleeding is stopped.

Device: Experimental: Medium pressure group of quantitative pressure patent hemostasis
The compression pressure was 125% of upper SBP. Pressure will be released by 5% hourly until the bleeding is stopped.

Experimental: High pressure group

This group will use the radial artery hemostatic device with quantitative pressure which will be the new patent product made by Shandong Weigao Group Medical Polymer Products Co. LTD,China. The compression pressure on radial artery after PCI was 130% of upper arm systolic BP measured preoperatively. Pressure will be released by 6% hourly until the bleeding is stopped.

Device: Experimental: High pressure group of quantitative pressure patent hemostasis
The compression pressure was 130% of upper SBP. Pressure will be released by 5% hourly until the bleeding is stopped.

Active Comparator: Control group

The control group will use the radial artery hemostatic device named by Radial Pressure Hemostat made by Rayon Medical Corporation,Japan (hemostatic device traditionally used in Peking University First Hospital). Pressure will be released hourly based on medical staff's experiences until the bleeding is stopped.

Device: Active Comparator: Conventional radial artery hemostat device
Radial artery hemostatic device. Pressure will be released hourly based on medical staff's experiences until the bleeding is stopped.

Outcome Measures

Primary Outcome Measures

  1. Incidence early radial artery occlusion [Within 24 hours after PCI]

    RAO occurs within 24 hours after PCI

  2. Incidence of access site bleeding [Within 24 hours after PCI]

    A hematoma formation requiring or not requiring specific therapy

Secondary Outcome Measures

  1. Compression time [through hemostasis completion,estimated to be an average of 4~6hours]

    The interval from the time of sheath removal to the time of hemostasis removal

  2. Incidence of hematoma [through hemostasis completion,estimated to be an average of 4~6hours]

    The incidence of subcutaneous hematoma in the distal skin of the compression site 24 h after the removal of the compression device

  3. Acute artery thrombus [Within 24 hours after PCI]

    Radial artery thrombus occurs but not radial artery occlusion

  4. Hemoglobin [baseline; 24 hours after PCI]

    value of hemoglobin

  5. The degree of pain [baseline; 24 hours after PCI]

    Pain level is classified as painless: 0; mild pain: 1~3; moderate pain: 4~6; severe pain: 7~10.

  6. Hand swelling [baseline; 24 hours after PCI]

    The circumference diameter of both hands was measured using a tape gauge contrast.

  7. False aneurysm [Within 24 hours after PCI]

    It refers to the lumen of the same as the artery formed by the blood through the perivascular tissue after arterial puncture.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Allen positive; Receiving radial coronary angiography or coronary intervention; Being conscious.

Exclusion Criteria:

The radial puncture fail the first time; Coagulopathy; Diagnosis of chronic kidney disease or cirrhosis; Radial artery malformation; Being treated with IIb / IIIa receptor antagonist.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University First Hospital Beijing China

Sponsors and Collaborators

  • Peking University First Hospital

Investigators

  • Study Chair: Zhenhui Tao, Peking University First Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Peking University First Hospital
ClinicalTrials.gov Identifier:
NCT05790603
Other Study ID Numbers:
  • 2023SF05
First Posted:
Mar 30, 2023
Last Update Posted:
Mar 30, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking University First Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 30, 2023